Serimmune is Other Healthcare Technology Systems in United States that focus on ml-based platform business. Founded in 2014. They cover business area such as developer, an immune mapping platform, circulate antibody, their diverse antigen, bacterial display peptide library, next-generation sequencing, custom bioinformatic, a repertoire, infection, allergen, microbiome organism, autoimmune disease, cancer, medical practitioner.
Other Healthcare Technology Systems
2014
( 10 years old in 2024 )
Ml-based Platform
-
150 Castilian Drive
Suite 100
Goleta, CA 93117
United States
Private
developeran immune mapping platformcirculate antibodytheir diverse antigenbacterial display peptide librarynext-generation sequencingcustom bioinformatica repertoireinfectionallergenmicrobiome organismautoimmune diseasecancermedical practitioner
* We use standard office opening hours in near Serimmune's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Serimmune is Other Healthcare Technology Systems business from United States that founded in 2014 (10 years old in 2024), Serimmune business is focusing on Ml-based Platform.
Serimmune headquarter office and corporate office address is located in 150 Castilian Drive Suite 100 Goleta, CA 93117 United States.
Serimmune was founded in United States.
In 2024, Serimmune is currently focus on ml-based platform sector.
Above is snippet of Google Trends for "ml-based platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Serimmune, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
